Oracle (NYSE:ORCL | ORCL Price Prediction) at $175 looks compelling on the data. The stock has been pulled into the broader software compression trade even as its Q4 report revealed a $638 billion AI backlog that locks in years of forward revenue.
Oracle sells database software, enterprise applications such as Fusion and NetSuite, and Oracle Cloud Infrastructure (OCI), which has emerged as a serious hyperscaler challenger by winning large-scale AI training and inferencing contracts. The stock has compressed from a 52-week high of $343.01, dragged down with peers as investors worry that AI agents will erode traditional software subscriptions and that Oracle’s capital intensity will outrun its earnings power.
The $638 Billion Reason This Pullback Looks Like a Gift
Q4 was a watershed. Cloud Infrastructure revenue grew 93% year over year to $5.79 billion, total cloud reached 52% of sales, and Remaining Performance Obligations jumped 363% to $638 billion, with $75 billion backed by customer-supplied or prepaid GPUs that reduce Oracle’s capital burden.
Management confirmed FY2027 revenue at $90 billion and raised non-GAAP EPS guidance to $8.05, with Q1 cloud growth guided to 58% to 64%. Mizuho reiterated Outperform with a $320 price target, calling the FY27 guide conservative.
The Capex Trap Bears Are Pricing In
FY26 free cash flow came in at negative $23.69 billion against $55.66 billion of capex, and management plans to raise roughly $40 billion more in debt and equity in FY27 on top of $218.7 billion in total liabilities.
Oracle disclosed a 21,000 employee reduction, about 13% of the workforce, with $1.84 billion in severance costs. Software license revenue fell 2% in Q4, feeding the bear thesis that the legacy book is eroding faster than cloud can offset, with concentration risk in a handful of mega AI contracts.
Why Patient Capital Could Still Wait Here
The hold case rests on visibility. Cash flow stays deeply negative through the buildout, and dilution from the planned $40 billion raise is a real overhang. A patient investor could wait for FCF to inflect or for proof that Q1 cloud growth lands inside the 58% to 64% guide before committing fresh capital.
The cost of that patience is missing the re-rating that typically follows when an RPO of this scale starts converting at scale.
What the Stock Actually Shows
Shares trade at $175.07 against a consensus 12-month target of $252.64, implying meaningful upside if analysts are right. The breakdown across 43 covering analysts currently sits at:
- Strong Buy: 6
- Buy: 30
- Hold: 6
- Sell: 1
Oracle trades at roughly 23x forward earnings with FY27 EPS growth guided near 18%. ORCL is down 13.82% over the past year and 9.63% year to date, while the S&P 500 is up 25.26% and 9.16% over the same periods.
The Setup: Asymmetric Risk/Reward at $175 With a Floor Near $160
At $175, the risk/reward skews favorable. The path to appreciation is mechanical. A $638 billion structural backlog insulates earnings from macro multiple re-rating, and Q1 results landing inside the 27% to 29% revenue guide should force analysts to mark up FY28 estimates as the RPO conversion curve becomes visible.
Risk/reward at this price is asymmetric. With a historical value floor near $160, downside is roughly single digits while the consensus target implies a move back toward $252. Multicloud AI Database grew 404% in Q4, and AWS regions are scaling from eight to 22 by Q4, real evidence the backlog is becoming revenue.
What invalidates the thesis: a slip in cloud growth below the guided range, an unexpectedly dilutive equity raise, or a major AI customer renegotiating commitments. Watch FCF trajectory and Q1 cloud growth quarter by quarter.
Owning Oracle at $175 effectively means owning a hyperscaler-grade backlog at a software multiple while the rest of the market is busy selling the input costs.
Top Gaining Stocks
Top Losing Stocks